Advanced search
Publication Cover
Future Medicinal Chemistry Volume 6, 2014 - Issue 4
Submit an article Journal homepage
294
Views
0
CrossRef citations to date
0
Altmetric
Review

Privileged S-Triazines: Structure and Pharmacological Applications

Dhruvin R Shaha Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad – 380 009, Gujarat, IndiaView further author information
,
Rahul P Modha Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad – 380 009, Gujarat, IndiaView further author information
&
Kishor H Chikhaliab Department of Chemistry, School of Sciences, Gujarat University, Ahmedabad – 380 009, Gujarat, India. [email protected]Correspondence[email protected]
View further author information
Pages 463-477 | Published online: 17 Mar 2014

Bibliography

  • Blotny G . Recent applications of 2, 4, 6-trichloro-1, 3, 5-triazine and its derivatives in organic synthesis.Tetrahedron62(41), 9507–9522 (2006).
  • Schroeder H , GrundmannC. Triazines. XIV. The extension of the pinner synthesis of monohydroxy-s-triazines to the aliphatic series. 2,4-dimethyl-s-triazine1–3. J. Am. Chem. Soc.78(11), 2447–2451 (1956).
  • Hatfield SE . Applications of Triazine Chemistry: Education, Remediation, and Drug Delivery. Thesis, Submitted to the Office of Graduate Studies of Texas A&M University, TX, USA (2007).
  • Tobe A , KobayashiT. Pharmacological studies on triazine derivatives V. Sedative and neuroleptic actions of 2-amino-4-(4-(2-hydroxyethyl)-piperazin-1-yl)-6-trifluoromethyl-s-triazine (TR-10). Jpn. J. Aerospace Med. Psychol.26(5), 559–570 (1976).
  • Patel RV , KumariP, RajaniDP, PannecouqueC, De Clercq E, Chikhalia KH. Antimicrobial, anti-TB, anticancer and anti-HIV evaluation of new s-triazine-based heterocycles. Future Med. Chem.4(9), 1053–1065 (2012).
  • Gavade SN , MarkadVL, KodamKM, ShingareMS, ManeDV. Synthesis and biological evaluation of novel 2, 4, 6-triazine derivatives as antimicrobial agents.Bioorg. Med. Chem. Lett.22(15), 5075–5077 (2012).
  • Solankee A , KapadiaK, ĈirićA, SokovićM, DoytchinovaI, GeronikakiA. Synthesis of some new s-triazine based chalcones and their derivatives as potent antimicrobial agents. Eur. J. Med. Chem.45(2), 510–518 (2010).
  • Patel RV , PatelAB, KumariP, ChikhaliaKH. Synthesis of novel 3-(5-sulfanyl-1, 3, 4-oxadiazol-2-yl)-2H-chromen-2-one condensed s-triazinyl piperazines and piperidines as antimicrobial agents.Med. Chem. Res.21(10), 3119–3132 (2012).
  • Modh RP , De Clercq E, Pannecouque C, Chikhalia KH. Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline-triazine derivatives. J. Enzyme Inhib. Med. Chem.29(1), 100–108 (2013).
  • Modh RP , PatelAC, ChikhaliaKH. Design, synthesis, antibacterial, and antifungal studies of novel 3-substituted coumarinyl-triazine derivatives.Heterocycl. Commun.19(5), 343–349 (2013).
  • Kumar A , MenonSK. Fullerene derivatized s-triazine analogues as antimicrobial agents. Eur. J. Med. Chem.44(5), 2178–2183 (2009).
  • Shanmugam M , NarayananK, ChidambaranathanV, KabilanS. Synthesis, spectral characterization and antimicrobial studies of novel s-triazine derivatives. Spectrochim. Acta A Mol. Biomol. Spectrosc.105, 383–390 (2013).
  • Bhat HR , PandeyPK, GhoshSK, SinghUP. Development of 4-aminoquinoline-1,3,5-triazine conjugates as potent antibacterial agent through facile synthetic route.Med. Chem. Res.22, 5056–5065 (2013).
  • Saleh M , AbbottS, PerronV, LauzonC, PenneyC, ZacharieB. Synthesis and antimicrobial activity of 2-fluorophenyl-4, 6-disubstituted [1,3,5] triazines.Bioorg. Med. Chem. Lett.20(3), 945–949 (2010).
  • Singh U , BhatH, GahtoriP. Antifungal activity, SAR and physicochemical correlation of some thiazole-1, 3, 5-triazine derivatives.J. Mycologie Médicale22(2), 134–141 (2012).
  • Srinivas K , SrinivasU, RaoVJ, BhanuprakashK, KishoreKH, MurtyU. Synthesis and antibacterial activity of 2,4,6-tri substituted s-triazines. Bioorg. Med. Chem. Lett.15(4), 1121–1123 (2005).
  • Kumar S , BhatHR, KumawatMK, SinghUP. Design and one-pot synthesis of hybrid thiazolidin-4-one-1, 3, 5-triazines as potent antibacterial agents against human disease-causing pathogens.New J. Chem.37, 581–584 (2013).
  • Bhat HR , GuptaSK, SinghUP. Discovery of potent, novel antibacterial hybrid conjugates from 4-aminoquinoline and 1, 3, 5-triazine: design, synthesis and antibacterial evaluation.RSC Adv.2(33), 12690–12695 (2012).
  • Sun X , CaoZ, SunY. N-chloro-alkoxy-s-triazine-based antimicrobial additives: preparation, characterization, and antimicrobial and biofilm-controlling functions. Ind. Eng. Chem. Res.48(2), 607–612 (2008).
  • Ma X , TanST, KhooCL, SimHM, ChanLW, ChuiWK. Synthesis and antimicrobial activity of N1-benzyl or N1-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diamines. Bioorg. Med. Chem. Lett.21(18), 5428–5431 (2011).
  • Venkatraj M , AriënKK, HeeresJet al. Synthesis, evaluation and structure–activity relationships of triazine dimers as novel antiviral agents. Bioorg. Med. Chem. Lett. 22, 7174–7178 (2012).
  • Xiong YZ , Chen F-E, Balzarini J, De Clercq E, Pannecouque C. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity. Eur. J. Med. Chem.43(6), 1230–1236 (2008).
  • Liu B , LeeY, ZouJet al. Discovery and SAR of a series of 4, 6-diamino-1, 3, 5-triazin-2-ol as novel non-nucleoside reverse transcriptase inhibitors of HIV-1. Bioorg. Med. Chem. Lett. 20(22), 6592–6596 (2010).
  • Lozano V , AguadoL, HoorelbekeBet al. Targeting HIV entry through interaction with envelope glycoprotein 120 (gp120): synthesis and antiviral evaluation of 1, 3, 5-triazines with aromatic amino acids. J. Med. Chem. 54(15), 5335–5348 (2011).
  • Xiong YZ , ChenFE, BalzariniJ, De Clercq E, Pannecouque C. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13. Chem. Biodivers.6(4), 561–568 (2009).
  • Jorgensen WL , BolliniM, ThakurVV, DomaoalRA, SpasovKA, AndersonKS. Efficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptase.J. Am. Chem. Soc.133(39), 15686–15696 (2011).
  • Kumar A , SrivastavaK, Raja Kumar S, Puri S, Chauhan P. Synthesis of 9-anilinoacridine triazines as new class of hybrid antimalarial agents. Bioorg. Med. Chem. Lett.19(24), 6996–6999 (2009).
  • Katiyar SB , SrivastavaK, PuriS, ChauhanP. Synthesis of 2-[3, 5-substituted pyrazol-1-yl]-4, 6-trisubstituted triazine derivatives as antimalarial agents.Bioorg. Med. Chem. Lett.15(22), 4957–4960 (2005).
  • Gravestock D , RousseauAL, LourensAC, MoleeleSS, Van Zyl RL, Steenkamp PA. Expeditious synthesis and biological evaluation of novel 2,N6-disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as potential antimalarials. Eur. J. Med. Chem.46(6), 2022–2030 (2011).
  • Gahtori P , GhoshSK, ParidaPet al. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition. Exp Parasitol. 130(3), 292–299 (2012).
  • Chellan P , LandKM, ShokarAet al. Di-and trinuclear ruthenium-, rhodium-, and iridium-functionalized pyridyl aromatic ethers: a new class of antiparasitic agents. Organometallics 32, 4793–4804 (2013).
  • Sunduru N , SharmaM, SrivastavaKet al. Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity. Bioorg. Med. Chem. 17(17), 6451–6462 (2009).
  • Bhat HR , SinghUP, YadavPSet al. Synthesis, characterization and antimalarial activity of hybrid 4-aminoquinoline-1, 3, 5-triazine derivatives. Arabian J. Chem. doi:10.1016/j.arabjc.2011.1007.1001 (2011) (Epub ahead of print).
  • Agarwal A , SrivastavaK, PuriS, ChauhanP. Syntheses of 2, 4, 6-trisubstituted triazines as antimalarial agents.Bioorg. Med. Chem. Lett.15(3), 531–533 (2005).
  • Ojha H , GahlotP, TiwariAK, PathakM, KakkarR. Quantitative structure activity relationship study of 2, 4, 6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase. Chem. Biol. Drug Des.77(1), 57–62 (2011).
  • Sharma M , ChauhanK, ChauhanSSet al. Synthesis of hybrid 4-anilinoquinoline triazines as potent antimalarial agents, their in silico modeling and bioevaluation as Plasmodium falciparum transketolase and β-hematin inhibitors. Med. Chem. Comm. 3(1), 71–79 (2012).
  • Bhat HR , SinghUP, GahtoriPet al. 4-aminoquinoline-1, 3, 5-triazine: design, synthesis, in vitro antimalarial activity and docking studies. New J. Chem. 37, 2654–2662 (2013).
  • Machakanur SS , PatilBR, BadigerDS, BakaleRP, GudasiKB, Annie Bligh S. Synthesis, characterization and anticancer evaluation of novel tri-arm star shaped 1, 3, 5-triazine hydrazones. J. Mol. Struct.1011, 121–127 (2012).
  • Malysheva YB , CombesS, AllegroDet al. Synthesis and biological evaluation of novel anticancer bivalent colchicine–tubulizine hybrids. Bioorg. Med. Chem. 20(14), 4271–4278 (2012).
  • Patel RV , KumariP, RajaniDP, ChikhaliaKH. Synthesis and studies of novel 2-(4-cyano-3-trifluoromethyl phenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial, antimycobacterial and anticancer agents. Eur. J. Med. Chem.46(9), 4354–4365 (2011).
  • Kumar GJ , BommaHS, SrihariEet al. Synthesis and anticancer activity of some new s-triazine derivatives. Med. Chem. Res. 22(12), 5973–5981 (2013).
  • Brzozowski Z , SączewskiF, GdaniecM. Synthesis, structural characterization and antitumor activity of novel 2, 4-diamino-1, 3, 5-triazine derivatives.Eur. J. Med. Chem.35(12), 1053–1064 (2000).
  • Brzozowski Z , SączewskiF. Synthesis and antitumor activity of novel 2-amino-4-(3, 5, 5-trimethyl-2-pyrazolino)-1, 3, 5-triazine derivatives.Eur. J. Med. Chem.37(9), 709–720 (2002).
  • Sączewski F , BulakowskaA, BednarskiP, GrunertR. Synthesis, structure and anticancer activity of novel 2, 4-diamino-1, 3, 5-triazine derivatives.Eur. J. Med. Chem.41(2), 219–225 (2006).
  • Zhu W , LiuY, ZhaoYet al. Synthesis and biological evaluation of novel 6-hydrazinyl-2, 4-bismorpholino pyrimidine and 1, 3, 5-triazine derivatives as potential antitumor agents. Arch. Pharm. 345(10), 812–821 (2012).
  • Koh M , LeeJC, MinC, MoonA. A novel metformin derivative, HL010183, inhibits proliferation and invasion of triple-negative breast cancer cells.Bioorg. Med. Chem.21(8), 2305–2313 (2013).
  • Menicagli R , SamaritaniS, SignoreG, VagliniF, Dalla Via L. In vitro cytotoxic activities of 2-alkyl-4, 6-diheteroalkyl-1, 3, 5-triazines: new molecules in anticancer research. J. Med. Chem.47(19), 4649–4652 (2004).
  • Arya K , DandiaA. Synthesis and cytotoxic activity of trisubstituted-1, 3, 5-triazines.Bioorg. Med. Chem. Lett.17(12), 3298–3304 (2007).
  • Paquin I , RaeppelS, LeitSet al. Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 18(3), 1067–1071 (2008).
  • Miller MS , PinsonJA, ZhengZ, JenningsIG, ThompsonPE. Regioselective synthesis of 5-and 6-methoxybenzimidazole-1, 3, 5-triazines as inhibitors of phosphoinositide 3-kinase.Bioorg. Med. Chem. Lett.23, 802–805 (2013).
  • Rewcastle GW , GamageSA, FlanaganJUet al. Synthesis and biological evaluation of novel analogues of the pan class I phosphatidylinositol 3-kinase (PI3K) inhibitor 2-(difluoromethyl)-1-[4, 6-di (4-morpholinyl)-1, 3, 5-triazin-2-yl]-1 H-benzimidazole (ZSTK474). J. Med. Chem. 54(20), 7105–7126 (2011).
  • Rewcastle GW , GamageSA, FlanaganJUet al. Synthesis and biological evaluation of novel phosphatidylinositol 3-kinase inhibitors: solubilized 4-substituted benzimidazole analogs of 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474). Eur. J. Med. Chem. 64, 137–147 (2013).
  • Poulsen A , WilliamsM, NagarajHMet al. Structure-based optimization of morpholino-triazines as PI3K and mTOR inhibitors. Bioorg. Med. Chem. Lett. 22(2), 1009–1013 (2012).
  • Richard DJ , VerheijenJC, YuK, ZaskA. Triazines incorporating (R)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3Kα. Bioorg. Med. Chem. Lett.20(8), 2654–2657 (2010).
  • Tanneeru K , ReddyBM, GuruprasadL. Three-dimensional quantitative structure–activity relationship (3D-QSAR) analysis and molecular docking of ATP-competitive triazine analogs of human mTOR inhibitors.Med. Chem. Res.21(7), 1207–1217 (2012).
  • Wurz RP , LiuL, YangKet al. Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1, 3, 5-triazine sulfonamide scaffold. Bioorg. Med. Chem. Lett. 22, 5714–5720 (2012).
  • Norman MH , AndrewsKL, BoYYet al. Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511. J. Med. Chem. 55(17), 7796–7816 (2012).
  • Zask A , VerheijenJC, RichardDJet al. Discovery of 2-ureidophenyltriazines bearing bridged morpholines as potent and selective ATP-competitive mTOR inhibitors. Bioorg. Med. Chem. Lett. 20(8), 2644–2647 (2010).
  • Verheijen JC , RichardDJ, CurranK, KaplanJ, YuK, ZaskA. 2-Arylureidophenyl-4-(3-oxa-8-azabicyclo [3.2.1] octan-8-yl) triazines as highly potent and selective ATP competitive mTOR inhibitors: optimization of human microsomal stability.Bioorg. Med. Chem. Lett.20(8), 2648–2653 (2010).
  • Smith AL , D‘angeloND, BoYYet al. Structure-based design of a novel series of potent, selective inhibitors of the class I phosphatidylinositol 3-kinases. J. Med. Chem. 55(11), 5188–5219 (2012).
  • Venkatesan AM , DehnhardtCM, Delos Santos E et al. Bis (morpholino-1, 3, 5-triazine) derivatives: potent adenosine 5´-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor. J. Med. Chem.53(6), 2636–2645 (2010).
  • Gupta L , SunduruN, VermaAet al. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b] indol-3-ylthio-1,3,5-triazines and [1,2,4] triazino [5,6-b] indol-3-yl thio-pyrimidines against Leishmania donovani. Eur. J. Med. Chem. 45(6), 2359–2365 (2010).
  • Sunduru N , AgarwalA, KatiyarSB, GoyalN, GuptaS, ChauhanP. Synthesis of 2, 4, 6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents.Bioorg. Med. Chem.14(23), 7706–7715 (2006).
  • Sunduru N , PalneS, ChauhanP, GuptaS. Synthesis and antileishmanial activity of novel 2, 4, 6-trisubstituted pyrimidines and 1, 3, 5-triazines.Eur. J. Med. Chem.44(6), 2473–2481 (2009).
  • Sharma M , ChauhanK, ShivahareRet al. Discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agents. J. Med. Chem. 56, 4374–4392 (2013).
  • Sunduru N , GuptaL, ChaturvediV, DwivediR, SinhaS, ChauhanP. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv. Eur. J. Med. Chem.45(8), 3335–3345 (2010).
  • Avupati VR , YejellaRP, ParalaVRet al. Synthesis, characterization and in vitro biological evaluation of some novel 1,3,5-triazine-Schiff base conjugates as potential antimycobacterial agents. Bioorg. Med. Chem. Lett. 23(21), 5968–5970 (2013).
  • Patel AB , PatelRV, KumariP, RajaniDP, ChikhaliaKH. Synthesis of potential antitubercular and antimicrobial s-triazine-based scaffolds via Suzuki cross-coupling reaction. Med. Chem. Res.22(1), 367–381 (2013).
  • Patel RV , KumariP, RajaniDP, ChikhaliaKH. Synthesis, characterization and pharmacological activities of 2-[4-cyano-(3-trifluoromethyl)phenyl amino)]-4-(4-quinoline/coumarin-4-yloxy)-6-(fluoropiperazinyl)-s-triazines. J. Fluorine Chem.132(9), 617–627 (2011).
  • Leftheris K , AhmedG, ChanRet al. The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase. J. Med. Chem. 47(25), 6283–6291 (2004).
  • Dianzani C , CollinoM, GallicchioMet al. Evaluation of in vitro anti-inflammatory activity of some 2-alkyl-4, 6-dimethoxy-1, 3, 5-triazines. J. Pharm. Pharmacol. 58(2), 219–226 (2006).
  • Vanderhoek R , AllenG, SettepaniJA. Bis (dimethylamino)-s-triazinyl antiinflammatory agents. J. Med. Chem.16(11), 1305–1306 (1973).
  • Veloso AJ , DharD, ChowAMet al. sym-triazines for directed multitarget modulation of cholinesterases and amyloid-β in alzheimer’s disease. ACS Chem. Neurosci. 4(2), 339–349 (2012).
  • Veloso AJ , ChowAM, DharDet al. Biological activity of sym-triazines with acetylcholine-like substitutions as multitarget modulators of alzheimer’s disease. ACS Chem. Neurosci. 4, 924–929 (2013).
  • Dao P , JarrayR, Le Coq J et al. Synthesis of novel diarylamino-1, 3, 5-triazine derivatives as FAK inhibitors with anti-angiogenic activity. Bioorg. Med. Chem. Lett.23, 4552–4556 (2013).
  • Klenke B , StewartM, BarrettMP, BrunR, GilbertIH. Synthesis and biological evaluation of s-triazine substituted polyamines as potential new anti-trypanosomal drugs. J. Med. Chem.44(21), 3440–3452 (2001).
  • Maarouf AR , FarahatAA, SelimKB, EisaHM. Synthesis and antiviral activity of benzimidazolyl-and triazolyl-1, 3, 5-triazines.Med. Chem. Res.21(6), 703–710 (2012).
  • Zacharie B , AbbottSD, Bienvenu J-FO et al. 2, 4, 6-trisubstituted triazines as protein a mimetics for the treatment of autoimmune diseases. J. Med. Chem.53(3), 1138–1145 (2010).
  • Yrjölä S , KalliokoskiT, LaitinenT, PosoA, ParkkariT, NevalainenT. Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of 2, 4, 6-trisubstituted 1, 3, 5-triazines as CB2 agonists.Eur. J. Pharm. Sci.48, 9–20 (2013).
  • Bregman H , BerryL, BuchananJLet al. Identification of a potent, state-dependent inhibitor of Nav1. 7 with oral efficacy in the formalin model of persistent pain. J. Med. Chem. 54(13), 4427–4445 (2011).
  • Gilligan PJ , ClarkeT, HeLet al. Synthesis and structure–activity relationships of 8-(pyrid-3-yl) pyrazolo [1, 5-a]-1, 3, 5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists. J. Med. Chem. 52(9), 3084–3092 (2009).
  • Ojwang JO , AliS, SmeeDF, MorreyJD, ShimasakiCD, SidwellRW. Broad-spectrum inhibitor of viruses in the Flaviviridae family. Antiviral Res.68(2), 49–55 (2005).
  • Zhao H , LiuY, CuiZ, BeattieD, GuY, WangQ. Design, synthesis, and biological activities of arylmethylamine substituted chlorotriazine and methylthiotriazine compounds.J. Agric. Food. Chem.59(21), 11711–11717 (2011).
  • Niyaz N, Guenthenspberger K, Hunter R, Brown A, Nugent J: EP2481730 A1 (2012).
  • Federico S , PaolettaS, CheongSLet al. Synthesis and biological evaluation of a new series of 1, 2, 4-triazolo [1, 5-a]-1, 3, 5-triazines as human A2A adenosine receptor antagonists with improved water solubility. J. Med. Chem. 54(3), 877–889 (2011).
  • Deng H , O‘keefeH, DavieCPet al. Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT). J. Med. Chem. 55(16), 7061–7079 (2012).
  • Gewald R , GrunwaldC, EgerlandU. Discovery of triazines as potent, selective and orally active PDE4 inhibitors.Bioorg. Med. Chem. Lett.23(15), 4308–4314 (2013).
  • Vidal-Mosquera M , Fernández-CarvajalA, MoureAet al. Triazine-based vanilloid 1 receptor open channel blockers: design, synthesis, evaluation, and SAR analysis. J. Med. Chem. 54(21), 7441–7452 (2011).
  • Oh KS , Koo OhB, Ho ParkCet al. Cardiovascular effects of a novel selective Rho kinase inhibitor, 2-(1H-indazole-5-yl) amino-4-methoxy-6-piperazino triazine (DW1865). Eur. J. Pharmacol.702, 218–226 (2013).
  • Shen M , ZhouS, LiY, PanP, ZhangL, HouT. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.Mol. Biosyst.9(3), 361–374 (2013).
  • Chen X , ZhanP, PannecouqueC, BalzariniJ, De Clercq E, Liu X. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. Eur. J. Med. Chem.51, 60–66 (2012).
  • Chen X , ZhanP, LiuXet al. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. 20(12), 3856–3864 (2012).
  • Ludovici DW , KavashRW, KuklaMJet al. Evolution of anti-HIV drug candidatespart 2: diaryltriazine (DATA) analogues. Bioorg. Med. Chem. Lett. 11(17), 2229–2234 (2001).
  • Wani MY , BhatAR, AzamA, ChoiI, AtharF. Probing the antiamoebic and cytotoxicity potency of novel tetrazole and triazine derivatives.Eur. J. Med. Chem.48, 313–320 (2012).
  • Keldsen N , HavsteenH, VergoteI, BertelsenK, JakobsenA. Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a Phase II study.Gynecol. Oncol.88(2), 118–122 (2003).
  • Chan JK , LoizziV, ManettaA, BermanML. Oral altretamine used as salvage therapy in recurrent ovarian cancer.Gynecol. Oncol.92(1), 368–371 (2004).
  • Malik IA . Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer.Jpn. J. Clin. Oncol.31(2), 69–73 (2001).
  • Cai B , HanY, LiuB, RenY, JiangS. Isolation and characterization of an atrazine – degrading bacterium from industrial wastewater in China.Lett. Appl. Microbiol.36(5), 272–276 (2003).
  • Luippold H , GoochP, BrewenJ. The production of chromosome aberrations in various mammalian cells by triethylenemelamine.Genetics88(2), 317–326 (1978).
  • Wackett L , SadowskyM, MartinezB, ShapirN. Biodegradation of atrazine and related s-triazine compounds: from enzymes to field studies. Appl. Microbiol. Biotechnol.58(1), 39–45 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.